The National Institutes of Health (NIH) has launched an adaptive phase 3 clinical trial to evaluate the safety and efficacy...
Read more
BD (Becton, Dickinson and Company), a leading global medical technology company, announced the CE mark and European availability of a...
Read more
Amgen announced positive topline Phase 2 results from the CodeBreaK 100 clinical study, evaluating sotorasib (proposed INN for AMG 510)...
Read more
Bristol Myers Squibb announced detailed results from True North, a pivotal, placebo-controlled Phase 3 trial evaluating oral Zeposia (ozanimod) as...
Read more
Antengene Corporation, a leading innovative biopharmaceutical company, and WuXi Biologics (WuXi Bio) announced that they have signed a strategic cooperation...
Read more
AstraZeneca’s long-acting antibody (LAAB) combination, AZD7442, will advance into two Phase III clinical trials in more than 6,000 participants at...
Read moreVir Biotechnology, Inc. and GlaxoSmithKline plc announced the global expansion to Phase 3 of the COMET-ICE (COVID-19 Monoclonal antibody Efficacy...
Read more
CureVac N.V., a clinical-stage biopharmaceutical company developing a new class of transformative medicines based on messenger ribonucleic acid ("mRNA"), announced...
Read more
Eisai Co. has entered into a joint research agreement with four research organizations (KAN Research Institute, National Center for Global...
Read more
Leading contract provider of integrated discovery, development and manufacturing services for biologics and bioconjugates, Abzena, has invested $60 million into...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
